EpiCast Research Report: Allergic Rhinitis - Epidemiology Market Trends and Forecast to 2023

ResearchMoz include new market research report"EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023: Industry Analysis, Size, Share, Growth, Trends And Forecast" to its huge collection of research reports. View Full Report at http://www.researchmoz.us/epicast-report-allergic-rhinitis-epidemiology-forecast-to-2023-report.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
ResearchMoz

ResearchMOZ

EpiCast Research Report: Allergic Rhinitis - Epidemiology Market Trends and Forecast to 2023

Albany, NY (PRWEB) April 08, 2014

Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis. According to the World Health Organization, an estimated 400 million people worldwide were affected with allergic rhinitis during 1996-2006.

View full report with complete TOC at http://www.researchmoz.us/epicast-report-allergic-rhinitis-epidemiology-forecast-to-2023-report.html.

According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate (AGR) of 0.17% during the forecast period. In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases.

To forecast the total prevalent cases of allergic rhinitis in the 7MM, GlobalData epidemiologists selected nationally representative studies that provided total prevalence of allergic rhinitis using uniform diagnostic criteria based on the self-reported prevalence of allergic rhinitis. The use of studies that provided uniform diagnostic criteria for total prevalence of allergic rhinitis facilitated meaningful comparison of the forecast total prevalent cases of allergic rhinitis across the 7MM. Additionally, GlobalData epidemiologists provide the total prevalent cases of allergic rhinitis segmented by the etiological type of allergic rhinitis (seasonal, perennial, and both), as well as by the severity of allergic rhinitis (mild, moderate, and severe) in these markets. In addition, GlobalData epidemiologists provide the population of allergic rhinitis cases segmented by sensitization to specific allergens in the six major markets (6MM) (France, Germany, Italy, Spain, UK and Japan), which are of utmost importance in the management of the condition.

Browse other published reports by GlobalData at http://www.researchmoz.us/publisher/globaldata-1.html.

Scope

The Allergic Rhinitis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends of allergic rhinitis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis segmented by sex and age (ages =18 years).
The allergic rhinitis epidemiology report is written and developed by Mastersand PhD-level epidemiologists.

The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
Quantify patient populations in the global allergic rhinitis market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic rhinitis therapeutics in each of the markets covered.

Browse all pharmaceutical market research reports at http://www.researchmoz.us/pharmaceutical-market-reports-38.html.

Related Reports -

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of the most common mental disorders in the world. MDD is a type of mood disorder characterized by persistent feelings of sadness, anger, loss, or frustration that can last from days to months and alternates with episodes of wellness. MDD is a highly debilitating condition that is associated with substantial morbidity and an enormous social and economic burden. The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.

View full report with complete TOC at http://www.researchmoz.us/epicast-report-major-depressive-disorder-epidemiology-forecast-to-2023-report.html.

EpiCast Report: Migraine - Epidemiology Forecast to 2023

In 2023, GlobalData epidemiologists forecast that the total prevalent cases of migraine in the 7MM remained almost the same, with 75.83 million total prevalent cases in 2013 and 76.38 million total prevalent cases, with an annual growth rate (AGR) of 0.07% in the forecast period. Throughout the forecast period, the US will have the highest number of total prevalent cases of migraine, with 29.61 million total prevalent cases in 2013 and 31.13 million total prevalent cases in 2023.

View full report with complete TOC at http://www.researchmoz.us/epicast-report-migraine-epidemiology-forecast-to-2023-report.html.

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2022

Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will be a significant public health problem as the elderly population increases around the world. ACS is classified into three disease entities based on evidence of heart muscle damage inferred from a persons symptoms, changes in the ST-tracing of the electrocardiogram (ECG), and levels of cardiac biomarkers that signify heart muscle death: ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). These three disease entities differ in their clinical characteristics, treatment approaches, and survival probabilities.

View full report with complete TOC at http://www.researchmoz.us/epicast-report-acute-coronary-syndrome-acs-epidemiology-forecast-to-2022-report.html.

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For more information, kindly contact:
Website@ http://www.researchmoz.us/
Email: sales(at)researchmoz(dot)us

Browse Blog -http://globalandchinamarkettrends.wordpress.com/.